NDC 71151-003

VALGANCICLOVIR

Valganciclovir

VALGANCICLOVIR is a Oral For Solution in the Human Prescription Drug category. It is labeled and distributed by Airis Pharma Pvt Ltd. The primary component is Valganciclovir Hydrochloride.

Product ID71151-003_d94fb558-d963-5c7a-e053-2a95a90a04b4
NDC71151-003
Product TypeHuman Prescription Drug
Proprietary NameVALGANCICLOVIR
Generic NameValganciclovir
Dosage FormFor Solution
Route of AdministrationORAL
Marketing Start Date2022-02-28
Marketing CategoryANDA /
Application NumberANDA210169
Labeler Nameairis PHARMA PVT LTD
Substance NameVALGANCICLOVIR HYDROCHLORIDE
Active Ingredient Strength50 mg/mL
Pharm ClassesCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71151-003-01

100 mL in 1 BOTTLE, DISPENSING (71151-003-01)
Marketing Start Date2022-02-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "VALGANCICLOVIR" or generic name "Valganciclovir"

NDCBrand NameGeneric Name
0603-6330ValganciclovirValganciclovir hydrochloride
0904-6796ValganciclovirValganciclovir
16714-765ValganciclovirValganciclovir
27241-158ValganciclovirValganciclovir
31722-832ValganciclovirValganciclovir
31722-837VALGANCICLOVIRVALGANCICLOVIR HYDROCHLORIDE
42291-875ValganciclovirValganciclovir hydrochloride
48433-124ValganciclovirValganciclovir
50268-787ValganciclovirValganciclovir
55111-762ValganciclovirValganciclovir
59651-444ValganciclovirValganciclovir hydrochloride powder,
60429-846ValganciclovirValganciclovir
63629-2288ValganciclovirValganciclovir hydrochloride
63739-076ValganciclovirValganciclovir
64380-153ValganciclovirValganciclovir hydrochloride
68084-965ValganciclovirValganciclovir
69097-277ValganciclovirValganciclovir
0004-0038Valcytevalganciclovir
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.